Prosecution Insights
Last updated: April 19, 2026
Application No. 18/508,297

FLUID HANDLING SYSTEM

Non-Final OA §DP
Filed
Nov 14, 2023
Examiner
BOUCHELLE, LAURA A
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Tc1 LLC
OA Round
1 (Non-Final)
80%
Grant Probability
Favorable
1-2
OA Rounds
3y 4m
To Grant
90%
With Interview

Examiner Intelligence

Grants 80% — above average
80%
Career Allow Rate
952 granted / 1188 resolved
+10.1% vs TC avg
Moderate +10% lift
Without
With
+10.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
47 currently pending
Career history
1235
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
43.9%
+3.9% vs TC avg
§102
28.3%
-11.7% vs TC avg
§112
15.6%
-24.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1188 resolved cases

Office Action

§DP
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application is being examined under the pre-AIA first to invent provisions. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1, 5, 18, 19 are rejected on the ground of nonstatutory double patenting as being unpatentable over claim 5, 6, 9 of U.S. Patent No. 11,850,414. Although the claims at issue are not identical, they are not patentably distinct from each other because it is clear that all of the elements of the application claim can be found in the patent claim. Regarding claim 1 of the application, claim 5 of the patent, which includes claim 1, recites a fluid handling system (claim 1, line 54) comprising: a console configured to connect with a first electrical interface that is configured to connect to a plurality of components of the fluid handling system, the console including a second electrical interface configured to connect with the first electrical interface, a display, and one or more hardware processors (claim 1, lines 55-60); a control system comprising the one or more hardware processors and a non- transitory memory storing instructions that, when executed, cause the control system to (claim 1, lines 64-67): detect an electrical signal from a first component of the plurality of components of the fluid handling system responsive to a caretaker performing a first instruction (claim 1, lines 1-3); and determine a system state of the fluid handling system based at least in part on the electrical signal from the first component (claim 1, lines 4-6); compare the system state with a predetermined state condition corresponding to said first instruction (claim 1, lines 7-8); and output an indication on the display of the system state; and a motor for driving a percutaneously insertable pump for bodily fluids (claim 1, lines 9-10), wherein the instructions further cause the control system to: i) determine a temperature of an impeller motor that rotates the impeller to pump blood and ii) shut off the impeller motor responsive to the determination of the temperature of the impeller motor. (claim 5, lines 28-33). The difference between the application claim and the patent claims lies in the fact that the patent claims includes more elements and is therefore more specific. It has been held that the generic claims is anticipated by the specific claim. See In re Goodman, 29USPQ2d 2010 (Fed. Cir. 1993). therefore, the application claim is not patentably distinct from the patent claims. Regarding claim 5 of the application, claim 6 of the patent recites the instructions further cause the control system to determine a current drawn by the motor and shut off the motor if the current drawn exceeds a predetermined threshold (claim 6, lines 35-38). Regarding claim 18 of the application, claim 1 of the patent recites a catheter assembly, a biocompatible fluid source, and a waste fluid line (claim 1, lines 61-63). Regarding claim 19 of the application, claim 9 of the patent, which includes claims 1 and 8, recites a fluid handling system (claim 1, line 54) comprising: a console configured to connect with a first electrical interface that is configured to connect to a plurality of components of the fluid handling system, the console including a second electrical interface configured to connect with the first electrical interface, a display, and one or more hardware processors (claim 1, lines 55-60); and a control system comprising the one or more hardware processors and a non- transitory memory storing instructions that, when executed, cause the control system to (claim 1, lines 64-67): detect an electrical signal from a first component of the plurality of components of the fluid handling system responsive to a caretaker performing a first instruction (claim 1, lines 1-3); determine a system state of the fluid handling system based at least in part on the electrical signal from the first component (claim 1, lines 4-6); compare the system state with a predetermined state condition corresponding to said first instruction (claim 1, lines 8-9); and output an indication on the display of the system state (claim 1, line 10); wherein the plurality of components comprises a priming pump and a catheter assembly, and wherein the instructions further cause the control system to: cause the priming pump to use a pressure to prime the catheter assembly with a biocompatible fluid (claim 8, lines 45-49); and monitor a back pressure or current draw of the priming pump and terminate the priming if the back pressure or current draw exceeds a predetermined threshold (claim 9, lines 52-54). The difference between the application claim and the patent claims lies in the fact that the patent claims includes more elements and is therefore more specific. It has been held that the generic claims is anticipated by the specific claim. See In re Goodman, 29USPQ2d 2010 (Fed. Cir. 1993). therefore, the application claim is not patentably distinct from the patent claims. Claims 2-4, 6, 7, 15, 20 are rejected on the ground of nonstatutory double patenting as being unpatentable over claim 5 of U.S. Patent No. 11,850,414 as applied to claim 1 above, and further in view of Smisson, III et al (US 7,975,491). Regarding claim 2, Smisson, III discloses a fluid handling system comprising a console 250, the console includes a display 1200 and a hardware processor (col. 25, lines 3-11; col. 26, lines 54-56, 65-67), and a control system 11100 comprising one or more hardware processors and a non-transitory memory storing instructions (col. 25, lines 1-11) causing the control system to perform in a similar manner to the claimed invention and further wherein the instructions cause the control system to generate on the display a first user interface including a visual indication of the first instruction (prime button 1220; fig. 12). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the instructions of claim 5 of the patent to include instructions causing a display of a visual indication of the first instruction as taught by Smisson to allow the user to monitor the progression of the setup of the of the device. Regarding claim 3, Smisson, III teaches that the instructions further cause the control system to generate one the display a second user interface including visual indication of a second instruction based on at least the comparison indicating that the system state is within the predetermined state condition and the first instruction is complete (col. 27, lines 33-35: after priming the pump may be operated in various modes as chosen by the operator – col. 30, line 63 – col. 31, line 5). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the instructions of claim 5 of the patent to include instructions causing a display including indication of a second a visual indication of the second instruction as taught by Smisson to allow the user to monitor the progression of the setup of the of the device. Regarding claim 4, Smisson, III discloses that if the system state is not within the predetermined state, the control system generates an error (col. 27, line 66 – col. 28, line 2). Smisson, III does not explicitly disclose that the error generates an alarm. However, Smisson, III teaches that various undesirable operating behaviors may cause an alarm to be generated (col. 26, lines 43-48). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the device of claim 5 of the patent and Smisson, III so that when the control system creates the error determined when the system state is not within the predetermined state condition an alarm is generated because Smisson, III acknowledges that various alarms can be generated when the device is not operating in the desired state so that the user can address the error. Regarding claim 6, Smisson, III discloses that one of the components is a catheter (col. 35, lines 12-13), and the instructions further cause the control system to determine a flow state of the fluid in the catheter and trigger an alarm based in the flow state is indicative of a blockage (col. 32, lines 4-6; col. 26, lines 43-48). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the device of claim 5 of the patent to include instructions that cause the system to determine a flow state and trigger an alarm if the flow state is indicative of a blockage as taught by Smisson, III to alert the user that the pump is not moving fluid as desired. Regarding claim 7, Smisson, III teaches that the plurality of components include a priming pump (col. 27, lines 50-55) and a catheter assembly (col. 35, lines 12-15), and wherein the instructions cause the control system to cause the priming pump to use positive pressure to prime the catheter with biocompatible fluid (col. 27, lines 50-55; it is understood that the fluid is biocompatible as this is the purpose of priming). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the device of claim 5 of the patent to include a priming pump and catheter assembly, and instructions that cause the system to cause the priming pump to prime the catheter as taught by Smisson, III to ready the catheter for use. Regarding claim 15, Smisson, III discloses that the instructions cause the control system to automatically begin a priming operation upon the system state being a predetermined condition (col. 27, lines 44-50). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the device of claim 5 of the patent to include instructions that cause the system to automatically begin a priming operation as taught by Smisson, III to remove user error in operation of the device. Regarding claim 20, Smisson, III discloses a fluid handling system comprising a console 250, the console includes a display 1200 and a hardware processor (col. 25, lines 3-11; col. 26, lines 54-56, 65-67), and a control system 11100 comprising one or more hardware processors and a non-transitory memory storing instructions (col. 25, lines 1-11) causing the control system to perform in a similar manner to the claimed invention and further wherein the instructions cause the control system to generate on the display a first user interface including a visual indication of the first instruction (prime button 1220; fig. 12). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the instructions of claim 5 of the patent to include instructions causing a display of a visual indication of the first instruction as taught by Smisson to allow the user to monitor the progression of the setup of the of the device. Claim 17 is rejected on the ground of nonstatutory double patenting as being unpatentable over claim 5 of U.S. Patent No. 11,850,414 as applied to claim 1 above, and further in view of Paden et al (US 2012/0048407). Regarding claim 17, Paden teaches a medical pump including a control system that determines system errors and includes instructions to display an alert history so that the operator can determine all the errors that occurred (page 10, para. 0135) which allows the user to determine if the treatment has occurred as prescribed. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the device of claim 5 of the patent to include instructions for generating on the display an alert history as taught by Paden to allow the user to determine if the procedure has been completed as prescribed. Claim Objections Claim 20 is objected to under 37 CFR 1.75 as being a substantial duplicate of claim 2. When two claims in an application are duplicates or else are so close in content that they both cover the same thing, despite a slight difference in wording, it is proper after allowing one claim to object to the other as being a substantial duplicate of the allowed claim. See MPEP § 608.01(m). Allowable Subject Matter Claims 8-14, 16 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Claims 1-7, 15, 17-20 are allowable over the prior art of record but for the double patenting rejections above. The following is a statement of reasons for the indication of allowable subject matter: the subject matter of the listed claims could not be found and was not suggested by the prior art of record. For further reasons for allowance, see prosecution history for parent application 17/144091. The closest prior art or record is Smisson, III et al (US 7,975,491) which teaches a fluid handling system comprising a console 250, the console includes a display 1200 and a hardware processor (col. 25, lines 3-11; col. 26, lines 54-56, 65-67), and a control system 11100 comprising one or more hardware processors and a non-transitory memory storing instructions (col. 25, lines 1-11) that when executed, cause the control system to detect an electrical signal from a first component of the plurality of component of the fluid handling system responsive to a caretaker performing a first instruction (col. 27, lines 44-66: caretaker performing priming by depressing and releasing prime input 1220, detect electrical signal from lower level sensor), determine a state of the fluid handling system based at least in part of the electrical signal from the first component (col 27, lines 61-62), compare the system state with a predetermined state condition corresponding to the first instruction (col. 27, line 62-66: determining if the predefined volume of fluid has been pumped after purging requires comparing volume of fluid pumped with predetermined volume of fluid), and output an indication on the display of the system state (col. 27, lines 5-7). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to LAURA A BOUCHELLE whose telephone number is (571)272-2125. The examiner can normally be reached Mon-Fri 8:00-5:00 CST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Bhisma Mehta can be reached at 571-272-3383. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. LAURA A. BOUCHELLE Primary Examiner Art Unit 3783 /LAURA A BOUCHELLE/Primary Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Nov 14, 2023
Application Filed
Mar 12, 2026
Non-Final Rejection — §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12594377
SYSTEMS AND METHODS FOR DELIVERING MICRODOSES OF MEDICATION
2y 5m to grant Granted Apr 07, 2026
Patent 12589205
WET INJECTION DETECTION AND PREVENTION SYSTEM AND METHOD
2y 5m to grant Granted Mar 31, 2026
Patent 12589025
INTRAOCULAR DEVICES, SYSTEMS, AND METHODS
2y 5m to grant Granted Mar 31, 2026
Patent 12589026
MICRO DOSING DEVICE AND METHOD OF ASSEMBLY OF THE MICRO DOSING DEVICE
2y 5m to grant Granted Mar 31, 2026
Patent 12589221
MECHANICALLY-DECOUPLED ACTUATION FOR ROBOTIC CATHETER SYSTEM
2y 5m to grant Granted Mar 31, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
80%
Grant Probability
90%
With Interview (+10.3%)
3y 4m
Median Time to Grant
Low
PTA Risk
Based on 1188 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month